NIH-funded research R01 grant

Gut-immune links in autoimmune disease via Tfh cells

Official title: Tfh cells: linking the gut microbiota to a gut-distal autoimmune disease

Funded at Ohio State University · NIH-11367077 · Data updated 2026-11-12

A study to understand how certain gut bacteria-related immune cells (Tfh17) may drive autoimmune diseases like RA and lupus.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startAugust 1, 2013
Project endMay 31, 2031
Funding year2026
Award (this year)$754,023
NIH project number2R01AI107117-11A1
Project IDNIH-11367077 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include adults with autoimmune diseases such as RA or lupus whose doctors are exploring gut-immune connections, or volunteers providing biological samples.

Less likely to help

People without autoimmune diseases or those not involved in gut-immune studies may not benefit from this research.

What this research studies

This project looks at how Tfh17 cells that originate in the gut might travel to other parts of the body and contribute to arthritis and other autoimmune conditions. Using mouse models and data from human patients, researchers will map where these cells come from, how they behave, and how interactions with gut microbes influence disease severity. The goal is to identify key steps in this gut-to-body signaling that could become targets for new treatments. The work connects gut biology, immune cell behavior, and autoimmune disease outcomes to inform future therapeutic approaches.

Why it matters

Potential benefit: If successful, the findings could reveal new targets to treat autoimmune diseases by interrupting gut-immune cell pathways.

How similar studies have gone: Previous work has linked gut-derived Tfh-like cells to disease activity, but the exact mechanisms and translational relevance remain to be confirmed.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Wu, Hsin-Jung Joyce — Ohio State University
  • Study coordinator: Wu, Hsin-Jung Joyce

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.